- Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…BioPharma Dive · 20d ago↗ source
- Another big premium hike on the horizonFDA's crackdown on online ketamine retailers, unprecedented health care premium hikes, and more health news from Morning RoundsSTAT · 20d ago↗ source
- Opinion: STAT+: What’s the right role for AI in dementia care?Three tricky questions about using AI in dementia care.STAT · 20d ago↗ source